Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options

Abstract

Vasoplegic syndrome is a common occurrence following cardiothoracic surgery and is characterized as a high-output shock state with poor systemic vascular resistance. The pathophysiology is complex and includes dysregulation of vasodilatory and vasoconstrictive properties of smooth vascular muscle cells. Specific bypass machine and patient factors play key roles in occurrence. Research into treatment of this syndrome is limited and extrapolated primarily from that pertaining to septic shock, but is evolving with the expanded use of catecholamine-sparing agents. Recent reports demonstrate potential benefit in novel treatment options, but large clinical trials are needed to confirm.

Keywords: Angiotensin II; Cardiopulmonary bypass; De-catecholaminization; Hydroxocobalamin; Shock; Vasoplegic syndrome.